The presence of anticentromere antibody has usually been associated with the CREST (calcinosis cutis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, telangiectasia) variant of scleroderma. 1 Anticentromere antibody has also been described in scleroderma and in overlaps or mixtures of CREST and scleroderma.26 Various authors have described occasional people with other diseases, including Raynaud's phenomenon alone or associated with systemic lupus erythematosus, rheumatoid arthritis, polyarthritis, or erythema nodosum.23 Other associations have included primary biliary cirrhosis, other chronic liver diseases, myositis, morphoea, linear scleroderma, Sjogren's syndrome, and relatives of patients with scleroderma.A9
The presence of anticentromere antibody is usually associated with a favourable prognosis, but some have not found this and have even described vasculitis."' 11 This study describes 10 disease. In this study only a small number of the people were found to have anticentromere antibodies -1% of those with systemic lupus erythematosus, nearly 2% of those with polyarthritis, and 5% of those with Raynaud's phenomenon. Anticentromere antibodies have been described in 0-08% of female blood donors, but these subjects were not clinically evaluated.20 The patients described here will need to be followed up to see if eventually they develop scleroderma or CREST. 
